HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Analysis of the relA gene product of Escherichia coli.

Abstract
The relA gene product, ATP: GTP 3'-pyrophosphotransferase (stringent factor) has been isolated in homogeneous form from an Escherichia coli strain polyploid for this gene at a yield of 1 mg/100 g cells and at a specific activity in a ribosome-activated assay at 37 degrees C of 120 mumol guanosine pentaphosphate formed min-1 mg protein-1. The specific activity in a methanol-activated assay at 25 degrees C was found to be 4 mumol guanosine pentaphosphate formed min-1 mg protein-1. These values are about 100 times higher than reported by others. Our further studies of this enzyme led to the following results. Antibodies raised against this enzyme inhibit the ribosome-activated synthesis of guanosine tetraphosphate and pentaphosphate but have no effect on the much slower synthesis, detected in the absence of ribosomes. The amount of stringent factor in the relA+ strain CP78 is estimated to about 1 copy per 200 ribosomes. The amount of antibody-binding material in CP79 (relA) is at least 5 times lower.
AuthorsF S Pedersen, N O Kjeldgaard
JournalEuropean journal of biochemistry (Eur J Biochem) Vol. 76 Issue 1 Pg. 91-7 (Jun 01 1977) ISSN: 0014-2956 [Print] England
PMID195816 (Publication Type: Journal Article)
Chemical References
  • Antibodies, Bacterial
  • Guanine Nucleotides
  • Phosphoric Acids
  • Ribosomal Proteins
  • Guanosine Triphosphate
  • Phosphotransferases
Topics
  • Antibodies, Bacterial
  • Antibody Formation
  • Binding Sites, Antibody
  • Drug Stability
  • Escherichia coli (enzymology)
  • Genes
  • Guanine Nucleotides (metabolism)
  • Guanosine Triphosphate (metabolism)
  • Phosphoric Acids
  • Phosphotransferases (isolation & purification, metabolism)
  • Polyploidy
  • Precipitin Tests
  • Ribosomal Proteins (isolation & purification)
  • Species Specificity

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: